NCT07385079 2026-02-03Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal CarcinomaSun Yat-sen UniversityPhase 3 Not yet recruiting412 enrolled
NCT07373990 2026-01-28Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal CarcinomaSun Yat-sen UniversityPhase 3 Not yet recruiting418 enrolled